Drug intelligence / Profile preview

Relicaps Advance

Development stage
Unknown
Lead developer
Minskintercaps
Modality
Small Molecules
Administration
Oral
01

Overview

Relicaps Advance is a hepatoprotective combination pharmaceutical product developed by Minskintercaps. It is composed of essential phospholipids (300 mg) and a complex of vitamins, including thiamine (B1), riboflavin (B2), pyridoxine (B6), cyanocobalamin (B12), nicotinamide (PP), and tocopherol (E). The essential phospholipids are primarily composed of phosphatidylcholine, which integrates into the lipid layer of damaged hepatocyte membranes, thereby restoring their structural integrity and enzymatic activity. The B-group vitamins serve as coenzymes in protein, lipid, and carbohydrate metabolism, while vitamin E provides antioxidant protection against lipid peroxidation. Relicaps Advance is indicated for the treatment of various liver conditions, including chronic hepatitis, liver cirrhosis, fatty liver disease (steatosis), and toxic liver damage resulting from alcohol or drug use.

Brand names
Relicaps Advance
Other names
Relicaps Advance
02

Targets

SCN1A (Voltage-gated sodium channel protein type 1 subunit alpha)

Beyond the preview

Go deeper on Relicaps Advance.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Relicaps Advance.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call